KRRP's API products and preparation workshop (imported and repackaged tablets, capsules, creams and tablets) has obtained the GMP certificate of China State Food and Drug Administration. The company has an independent R&D new product department, and a high-quality, efficient and professional R&D team is actively developing new products in various key treatment fields. We have a strong new product portfolio, and many products are being registered at different stages. In recent years, the company has pioneered and innovated in brand building, patent technology transformation and technology introduction, and has successively won honorary titles such as "Kunshan High-tech Enterprise", "Suzhou High-tech Enterprise" and "Jiangsu Foreign R&D Institute". We will strive for perfection, constantly improve work efficiency and quality standards, upgrade the technical level, enhance the core competitiveness of enterprises, and achieve a new leap for the company.
KRRP has established its own brand in cardiovascular and cerebrovascular diseases, central nervous system, gastroenterology, cardiology, endocrinology, dermatology, rheumatism and other fields. It has branches and offices in major cities and regions such as Shanghai, Beijing, Guangzhou and Nanjing, and its sales network covers all provinces in China. Its products are sold in many hospitals and pharmacies in China.